<DOC>
	<DOCNO>NCT00199173</DOCNO>
	<brief_summary>This Phase III trial compare hepatic intra-arterial injection Yttrium-90 microspheres ( selective internal radiation [ SIR ] spheres ) versus infusional intravenous ( IV ) 5FU colorectal cancer metastatic liver refractory standard IV chemotherapy .</brief_summary>
	<brief_title>Comparing Hepatic Intra-arterial Injection Yttrium-90 Microspheres Versus Fluorouracil ( 5FU ) Colorectal Cancer Metastatic Liver Only</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Histologically proven colorectal adenocarcinoma , metastatic liver . Failure prior chemotherapy advance colorectal cancer . Adequate laboratory value hematologic , renal liver function World Health Organization ( WHO ) performance status ( PS ) &lt; = 2 Written consent Pregnant lactating patient Other tumor type adenocarcinoma ( leiomyosarcoma ; lymphoma ) . Patients cirrhosis chronic liver disease Thrombosis hepatic main artery portal vein Lung shunt &gt; 20 % determined nuclear medicine breakthrough scan Patients serum bilirubin &gt; 1.0 x upper limit normal ( ULN ) AST and/or ALT and/or alkaline phosphatase &gt; 5 x ULN Patients concurrent within 4 week period administration experimental drug . Other serious illness medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>intraarterial hepatic injection</keyword>
	<keyword>yttrium load microspheres</keyword>
	<keyword>colorectal neoplasm metastatic liver</keyword>
</DOC>